In addition the treatment with the MIX was associated with increased SIRT1 levels in senescent HUVECs and with decreased pro-Caspase-1 activation in inflamed THP-1, which are molecules involved in inflammation, aging and ARDs (Cordero et al. 2018). Here, MIXL1 is linked to acute respiratory distress syndrome.